Calciumfolinat Fresenius Kabi

Calciumfolinat Fresenius Kabi is a pharmaceutical preparation of folinic acid, used to support certain chemotherapy treatments and address folate deficiencies. This medication is administered via intramuscular or intravenous routes.

Folinic acid, also known as leucovorin, is primarily used to counteract the toxic effects of folate antagonists, such as methotrexate, during chemotherapy. It plays a crucial role in enhancing the effectiveness of specific cancer treatments by restoring normal folate metabolism. Additionally, it is employed to treat folate deficiencies that may arise from various medical conditions or nutritional imbalances.

When administered as directed, folinic acid helps to mitigate the side effects of certain chemotherapy drugs, such as methotrexate, by replenishing folate levels in the body. This can lead to improved overall well-being and reduced toxicity. Common effects may include temporary improvements in appetite and energy levels, as folinic acid supports cellular function and growth.

Folinic acid should be used under the supervision of a healthcare professional, especially when administered intravenously or intramuscularly. Patients with known allergies to folic acid or any components of the formulation should exercise caution. It is important to follow the prescribed dosage and administration guidelines to avoid potential complications.

Folinic acid may interact with certain medications, particularly those that affect folate metabolism or are used in cancer treatments. It is advisable to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to prevent adverse interactions. Alcohol consumption should be moderated, as it may influence the effectiveness of folinic acid.